Human Papillomavirus-Related Squamous Cell Carcinoma

Human Papillomavirus-Related Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

80 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 41
Recruiting: 23
Ph III recruiting: 1
Growth YoY: —
Industry share: 20%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05108870	TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers	active not recruiting	Phase 1 / Phase 2	35	University of ChicagoOTHER	1	Apr 24, 2026	clinicaltrials
NCT03260023	Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers	active not recruiting	Phase 1 / Phase 2	143	TransgeneINDUSTRY	3	Feb 5, 2026	clinicaltrials